Institute of Biomedical Research Corp. Stock Analysis MRES
Institute of BioMedical Research Corp. engages in research and development, quality control and standardization of pharmaceuticals, cosmetics and food products. The company is headquartered in Niksic, Niksic. The company went IPO on 2000-10-27. The firm's services include scientific research and biomedical services, such as research and development, quality control, standardization of pharmaceuticals, cosmetics and food products. The firm also provides long-term biomedical and environmental research projects, develops new diagnostic biomedical technologies and experimental medical treatments. The firm's products include Aerosan, MicrobEX, Microbicidal Towels KleNET, OralNet, Oral Ocean Power and Purilair. The company offers electro medical devices, such as BioMed 2000 XT with Timer, BioStim INF, QuadStar Elite, QuadStar II, Pain Gone piezo-electric pain relief and Portable Ultra Sound Device. The company offers various services, including quality control services, regulatory services, healthcare services, environmental analyses, building decontamination, and environmental protection and management.
Read More Institute of Biomedical Research Corp (MRES) Chart
Key Statistics of Institute of Biomedical Research Corp (MRES)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
2.01MP/E Ratio (TTM)
-52 Week Range
Market Cap
4.12MAvg. Volume
1.34MDividend Yield
-Financial Metrics & Statements of Institute of Biomedical Research Corp (MRES)
FAQ's for Institute of Biomedical Research Corp (MRES)
- According to Musaffa’s Shariah screening methodology, Institute of Biomedical Research Corp (MRES) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.